Buenos Aires, Argentina

Mauricio Farez

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mauricio Farez. Retrieved from https://idiyas.com/inventor/mauricio-farez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mauricio Farez - Innovator in Autoimmune Disease Treatment

Introduction

Mauricio Farez is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach focuses on the use of melatonin to address the challenges faced by individuals with multiple sclerosis.

Latest Patents

Farez holds a patent titled "Melatonin in autoimmune disease - Methods for treating, or reducing risk of developing, seasonal worsening of multiple sclerosis (MS) in a subject who has MS, comprising administering a melatonin agonist to a subject." This patent highlights his commitment to improving the quality of life for those affected by MS.

Career Highlights

Mauricio Farez is affiliated with Brigham and Women's Hospital, Inc., where he continues to advance his research and clinical practice. His work is characterized by a dedication to understanding the complexities of autoimmune disorders and finding effective treatment options.

Collaborations

Farez collaborates with esteemed colleagues, including Jorge Correale and Francisco Javier Quintana. These partnerships enhance the depth and breadth of his research, contributing to the advancement of knowledge in the field.

Conclusion

Mauricio Farez's innovative work in the treatment of multiple sclerosis through melatonin administration showcases his dedication to improving patient outcomes. His contributions to the medical community are invaluable and continue to inspire future research in autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…